Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli

Diatchenko, Ludaa; Nackley, Andrea G.a; Slade, Gary D.b; Bhalang, Kanokpornc; Belfer, Innad,e; Max, Mitchell B.d; Goldman, Davide; Maixner, Williama,f,*

doi: 10.1016/j.pain.2006.05.024
Research papers
Buy
SDC

Variations in the gene encoding catechol-O-methyltransferase (COMT) are linked to individual differences in pain sensitivity. A single nucleotide polymorphism (SNP) in codon 158 (val158met), which affects COMT protein stability, has been associated with the human experience of pain. We recently demonstrated that three common COMT haplotypes, which affect the efficiency of COMT translation, are strongly associated with a global measure of pain sensitivity derived from individuals’ responses to noxious thermal, ischemic, and pressure stimuli. Specific haplotypes were associated with low (LPS), average (APS), or high (HPS) pain sensitivity. Although these haplotypes included the val158met SNP, a significant association with val158met variants was not observed. In the present study, we examined the association between COMT genotype and specific pain-evoking stimuli. Threshold and tolerance to thermal, ischemic, and mechanical stimuli, as well as temporal summation to heat pain, were determined. LPS/LPS homozygotes had the least, APS/APS homozygotes had average, and APS/HPS heterozygotes had the greatest pain responsiveness. Associations were strongest for measures of thermal pain. However, the rate of temporal summation of heat pain did not differ between haplotype combinations. In contrast, the val158met genotype was associated with the rate of temporal summation of heat pain, but not with the other pain measures. This suggests that the val158met SNP plays a primary role in variation in temporal summation of pain, but that other SNPs of the COMT haplotype exert a greater influence on resting nociceptive sensitivity. Here, we propose a mechanism whereby these two genetic polymorphisms differentially affect pain perception.

aCenter for Neurosensory Disorders, University of North Carolina at Chapel Hill, NC, USA

bAustralian Researcher Center for Population Oral Health, Dental School, University of Adelaide, Australia

cDepartment of Oral Medicine, Chulalongkorn University, Bangkok, Thailand

dNIDCR, NIH, DHHS, Bethesda, MD, USA

eNIAAA, NIH, DHHS, Rockville, MD, USA

fDepartment of Pharmacology, University of North Carolina at Chapel Hill, NC, USA

*Corresponding author. Tel.: +1 919 966 3756; fax: +1 919 966 3683.

E-mail address:Bill_Maixner@dentistry.unc.edu

Submitted September 19, 2005; revised April 12, 2006; accepted May 8, 2006.

© 2006 Lippincott Williams & Wilkins, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website